China Goes Prime Time on Capitol Hill, and 3 Things Determining How the Economy Lands 2/28/23
CNBC's "Fast Money"
00:00
Sirupta, Up There, 15% Now, Mel.
On their fourth quarter earnings update, Nova Vax warned about their ability to continue as a going concern. They pointed to uncertainties around three areas: 23 revenue, US government funding, and pending arbitration. You're seeing Nova Vax down there 25%. The call is ongoing.
Play episode from 19:21
Transcript
